Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Manufacturers Will Have 38 Days To Pay Part D Donut Hole Drug Discount Invoices

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS releases final drug manufacturer agreement for the Medicare Part D program that provides 50 percent drug discounts to enrollees in the coverage gap.

You may also be interested in...



Part D Discount Participating Manufacturers List Released; All Medically Necessary Drugs Covered, CMS Says

CMS releases the names of drug firms that have signed contracts to provide 50% discounts on brands and certain generics when Medicare enrollees reached Part D's coverage gap. Contracts will ensure that all medically necessary drugs will be covered, agency says.

Part D Discount Participating Manufacturers List Released; All Medically Necessary Drugs Covered, CMS Says

CMS releases the names of drug firms that have signed contracts to provide 50% discounts on brands and certain generics when Medicare enrollees reached Part D's coverage gap. Contracts will ensure that all medically necessary drugs will be covered, agency says.

CMS Open To Discussion On Manufacturer Payment Time For Part D Discounts

The Centers for Medicare and Medicaid Services is seeking feedback on its proposal that drug firms pay Medicare Part D plans for donut-hole drug discounts within 14 days of invoice

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071066

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel